Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
New Zealand · Delayed Price · Currency is NZD | Market Cap | 21.61B +9.7% |
| Revenue (ttm) | 2.16B +14.2% |
| Net Income | 437.00M +144.8% |
| EPS | 0.74 +144.1% |
| Shares Out | 587.29M |
| PE Ratio | 49.81 |
| Forward PE | 42.81 |
| Dividend | 0.43 (1.19%) |
| Ex-Dividend Date | Dec 3, 2025 |
| Volume | 177,990 |
| Average Volume | 419,974 |
| Open | 36.27 |
| Previous Close | 36.80 |
| Day's Range | 36.13 - 36.74 |
| 52-Week Range | 34.61 - 41.40 |
| Beta | 0.86 |
| RSI | 43.96 |
| Earnings Date | May 25, 2026 |
About NZE:FPH
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio... [Read more]
Financial Performance
In fiscal year 2025, NZE:FPH's revenue was 2.02 billion, an increase of 15.96% compared to the previous year's 1.74 billion. Earnings were 377.20 million, an increase of 184.46%.
Financial StatementsNews
Fisher and Paykel Healthcare Stock Trades at 48x Earnings — And Long-Term Holders Aren’t Selling
Certain stocks don’t make headlines unless something goes wrong, don’t trend on Reddit, and don’t appear on CNBC’s lower thirds. Among them is Fisher & Paykel Healthcare. It has the reputation of a br...